{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T06:58:15Z","timestamp":1768201095178,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006197","name":"The A.P. M\u00f8ller Foundation for the Advancement of Medical Science","doi-asserted-by":"crossref","award":["Journalnr. 17-L-0254"],"award-info":[{"award-number":["Journalnr. 17-L-0254"]}],"id":[{"id":"10.13039\/501100006197","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Danish Osteoporosis Association","award":["-"],"award-info":[{"award-number":["-"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00198-022-06536-2","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T19:02:26Z","timestamp":1660935746000},"page":"2595-2605","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Biochemical and clinical manifestations in adults with hypophosphatasia: a national cross-sectional study"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4571-0439","authenticated-orcid":false,"given":"Nicola","family":"Hepp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7944-8910","authenticated-orcid":false,"given":"Anja Lisbeth","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8436-7744","authenticated-orcid":false,"given":"Morten","family":"Duno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9624-5210","authenticated-orcid":false,"given":"Niklas Rye","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4290-0480","authenticated-orcid":false,"given":"Jens-Erik Beck","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"6536_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrendo.2016.14","volume":"12","author":"MP Whyte","year":"2016","unstructured":"Whyte MP (2016) Hypophosphatasia-aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 12:233\u2013246","journal-title":"Nat Rev Endocrinol"},{"issue":"Suppl 2","key":"6536_CR2","first-page":"380","volume":"10","author":"C Rockman-Greenberg","year":"2013","unstructured":"Rockman-Greenberg C (2013) Hypophosphatasia. Pediatr Endocrinol Rev 10(Suppl 2):380\u2013388","journal-title":"Pediatr Endocrinol Rev"},{"key":"6536_CR3","doi-asserted-by":"publisher","first-page":"7666","DOI":"10.1073\/pnas.85.20.7666","volume":"85","author":"MJ Weiss","year":"1988","unstructured":"Weiss MJ, Cole DEC, Ray K et al (1988) A missense mutation in the human liver\/bone\/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia. Proc Natl Acad Sci U S A 85:7666\u20137669. https:\/\/doi.org\/10.1073\/pnas.85.20.7666","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6536_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12018-013-9139-0","volume":"11","author":"C Hofmann","year":"2013","unstructured":"Hofmann C, Girschick HJ, Mentrup B et al (2013) Clinical aspects of hypophosphatasia: an update. Clin Rev Bone Miner Metab 11:60\u201370. https:\/\/doi.org\/10.1007\/s12018-013-9139-0","journal-title":"Clin Rev Bone Miner Metab"},{"key":"6536_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom10121648","volume":"10","author":"D Liedtke","year":"2020","unstructured":"Liedtke D, Hofmann C, Jakob F et al (2020) Tissue-nonspecific alkaline phosphatase\u2014a gatekeeper of physiological conditions in health and a modulator of biological environments in disease. Biomolecules 10:1\u201328","journal-title":"Biomolecules"},{"key":"6536_CR6","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00774-017-0888-6","volume":"36","author":"A Taillandier","year":"2018","unstructured":"Taillandier A, Domingues C, Dufour A et al (2018) Genetic analysis of adults heterozygous for ALPL mutations. J Bone Miner Metab 36:723\u2013733. https:\/\/doi.org\/10.1007\/s00774-017-0888-6","journal-title":"J Bone Miner Metab"},{"key":"6536_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1469-1809.2011.00642.x","volume":"75","author":"E Mornet","year":"2011","unstructured":"Mornet E, Yvard A, Taillandier A et al (2011) A molecular-based estimation of the prevalence of hypophosphatasia in the European population. Ann Hum Genet 75:439\u2013445. https:\/\/doi.org\/10.1111\/j.1469-1809.2011.00642.x","journal-title":"Ann Hum Genet"},{"key":"6536_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41431-020-00732-6","volume":"29","author":"E Mornet","year":"2021","unstructured":"Mornet E, Taillandier A, Domingues C et al (2021) Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation. Eur J Hum Genet 29:289\u2013299. https:\/\/doi.org\/10.1038\/s41431-020-00732-6","journal-title":"Eur J Hum Genet"},{"key":"6536_CR9","doi-asserted-by":"publisher","unstructured":"H\u00f6gler W, Langman C, Gomes Da Silva H et al (2019) Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry. BMC Musculoskelet Disord 20.https:\/\/doi.org\/10.1186\/s12891-019-2420-8","DOI":"10.1186\/s12891-019-2420-8"},{"key":"6536_CR10","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.metabol.2016.07.006","volume":"65","author":"TJ Weber","year":"2016","unstructured":"Weber TJ, Sawyer EK, Moseley S et al (2016) Burden of disease in adult patients with hypophosphatasia: results from two patient-reported surveys. Metabolism 65:1522\u20131530. https:\/\/doi.org\/10.1016\/j.metabol.2016.07.006","journal-title":"Metabolism"},{"key":"6536_CR11","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1002\/jbmr.4130","volume":"35","author":"L Seefried","year":"2020","unstructured":"Seefried L, Dahir K, Petryk A et al (2020) Burden of illness in adults with hypophosphatasia: data from the Global Hypophosphatasia Patient Registry. J Bone Miner Res 35:2171\u20132178. https:\/\/doi.org\/10.1002\/jbmr.4130","journal-title":"J Bone Miner Res"},{"key":"6536_CR12","doi-asserted-by":"publisher","unstructured":"Durrough C, Colazo JM, Simmons J et al (2021) Characterization of physical, functional, and cognitive performance in 15 adults with hypophosphatasia. Bone 142.https:\/\/doi.org\/10.1016\/j.bone.2020.115695","DOI":"10.1016\/j.bone.2020.115695"},{"key":"6536_CR13","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s00198-017-4087-z","volume":"28","author":"T Schmidt","year":"2017","unstructured":"Schmidt T, Mussawy H, Rolvien T et al (2017) Clinical, radiographic and biochemical characteristics of adult hypophosphatasia. Osteoporos Int 28:2653\u20132662. https:\/\/doi.org\/10.1007\/s00198-017-4087-z","journal-title":"Osteoporos Int"},{"key":"6536_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00198-018-4691-6","volume":"30","author":"JM Colazo","year":"2019","unstructured":"Colazo JM, Hu JR, Dahir KM, Simmons JH (2019) Neurological symptoms in hypophosphatasia. Osteoporos Int 30:469\u2013480. https:\/\/doi.org\/10.1007\/s00198-018-4691-6","journal-title":"Osteoporos Int"},{"key":"6536_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bone.2013.01.024","volume":"54","author":"KE Berkseth","year":"2013","unstructured":"Berkseth KE, Tebben PJ, Drake MT et al (2013) Clinical spectrum of hypophosphatasia diagnosed in adults. Bone 54:21\u201327. https:\/\/doi.org\/10.1016\/j.bone.2013.01.024","journal-title":"Bone"},{"key":"6536_CR16","doi-asserted-by":"publisher","unstructured":"Bloch-Zupan A, Vaysse F (2017) Hypophosphatasia: oral cavity and dental disorders. Arch Pediatr 24:5S80\u20135S84. https:\/\/doi.org\/10.1016\/S0929-693X(18)30020-4","DOI":"10.1016\/S0929-693X(18)30020-4"},{"key":"6536_CR17","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1007\/s00198-018-4552-3","volume":"29","author":"F Genest","year":"2018","unstructured":"Genest F, Seefried L (2018) Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia\u2014not atypical at all. Osteoporos Int 29:1815\u20131825. https:\/\/doi.org\/10.1007\/s00198-018-4552-3","journal-title":"Osteoporos Int"},{"key":"6536_CR18","doi-asserted-by":"publisher","unstructured":"Desborough R, Nicklin P, Gossiel F et al (2021) Clinical and biochemical characteristics of adults with hypophosphatasia attending a metabolic bone clinic. Bone 144.https:\/\/doi.org\/10.1016\/j.bone.2020.115795","DOI":"10.1016\/j.bone.2020.115795"},{"key":"6536_CR19","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","volume":"98","author":"JL Mill\u00e1n","year":"2016","unstructured":"Mill\u00e1n JL, Whyte MP (2016) Alkaline phosphatase and hypophosphatasia. Calcif Tissue Int 98:398\u2013416","journal-title":"Calcif Tissue Int"},{"key":"6536_CR20","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1172\/JCI112031","volume":"76","author":"MP Whyte","year":"1985","unstructured":"Whyte MP, Mahuren JD, Vrabel LA, Coburn SP (1985) Markedly increased circulating pyridoxal-5\u2019-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism. J Clin Invest 76:752\u2013756. https:\/\/doi.org\/10.1172\/JCI112031","journal-title":"J Clin Invest"},{"key":"6536_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2021.101101","volume":"15","author":"N Hepp","year":"2021","unstructured":"Hepp N, Frederiksen AL, Duno M et al (2021) Biochemical, clinical and genetic characteristics in adults with persistent hypophosphatasaemia; data from an endocrinological outpatient clinic in Denmark. Bone Rep 15:101101. https:\/\/doi.org\/10.1016\/j.bonr.2021.101101","journal-title":"Bone Rep"},{"key":"6536_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12018-016-9206-4","volume":"14","author":"J Shepherd","year":"2016","unstructured":"Shepherd J (2016) Evaluation of sarcopenia by DXA. Clin Rev Bone Miner Metab 14:45\u201349","journal-title":"Clin Rev Bone Miner Metab"},{"key":"6536_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1385\/JCD:4:4:373","volume":"4","author":"SL Greenspan","year":"2001","unstructured":"Greenspan SL, Von Stetten E, Emond SK et al (2001) Instant vertebral assessment: a noninvasive dual X-ray absorptiometry technique to avoid misclassification and clinical mismanagement of osteoporosis. J Clin Densitom 4:373\u2013380. https:\/\/doi.org\/10.1385\/JCD:4:4:373","journal-title":"J Clin Densitom"},{"key":"6536_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115695","author":"C Durrough","year":"2021","unstructured":"Durrough C, Colazo JM, Simmons J et al (2021) Characterization of physical, functional, and cognitive performance in 15 adults with hypophosphatasia. Bone. https:\/\/doi.org\/10.1016\/j.bone.2020.115695","journal-title":"Bone"},{"key":"6536_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1519\/JPT.0000000000000166","volume":"42","author":"IH Bruun","year":"2019","unstructured":"Bruun IH, Mogensen CB, N\u00f8rgaard B et al (2019) Validity and responsiveness to change of the 30-second chair-stand test in older adults admitted to an emergency department. J Geriatr Phys Ther 42:265\u2013274. https:\/\/doi.org\/10.1519\/JPT.0000000000000166","journal-title":"J Geriatr Phys Ther"},{"key":"6536_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0304-3959(83)90126-4","volume":"17","author":"DD Price","year":"1983","unstructured":"Price DD, McGrath PA, Rafii A, Buckingham B (1983) The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 17:45\u201356. https:\/\/doi.org\/10.1016\/0304-3959(83)90126-4","journal-title":"Pain"},{"key":"6536_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"6536_CR28","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/jbmr.2110","volume":"29","author":"N Gua\u00f1abens","year":"2014","unstructured":"Gua\u00f1abens N, Mumm S, M\u00f6ller I et al (2014) Calcific periarthritis as the only clinical manifestation of hypophosphatasia in middle-aged sisters. J Bone Miner Res 29:929\u2013934. https:\/\/doi.org\/10.1002\/jbmr.2110","journal-title":"J Bone Miner Res"},{"key":"6536_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bone.2017.02.011","volume":"102","author":"MP Whyte","year":"2017","unstructured":"Whyte MP (2017) Hypophosphatasia: an overview For 2017. Bone 102:15\u201325. https:\/\/doi.org\/10.1016\/j.bone.2017.02.011","journal-title":"Bone"},{"key":"6536_CR30","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00198-020-05345-9","volume":"31","author":"ML Bianchi","year":"2020","unstructured":"Bianchi ML, Bishop NJ, Gua\u00f1abens N et al (2020) Hypophosphatasia in adolescents and adults: overview of diagnosis and treatment. Osteoporos Int 31:1445\u20131460","journal-title":"Osteoporos Int"},{"key":"6536_CR31","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00198-020-05612-9","volume":"32","author":"F Genest","year":"2021","unstructured":"Genest F, Clau\u00dfen L, Rak D, Seefried L (2021) Bone mineral density and fracture risk in adult patients with hypophosphatasia. Osteoporos Int 32:377\u2013385. https:\/\/doi.org\/10.1007\/s00198-020-05612-9","journal-title":"Osteoporos Int"},{"key":"6536_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-012-9672-8","author":"JL Mill\u00e1n","year":"2013","unstructured":"Mill\u00e1n JL (2013) The role of phosphatases in the initiation of skeletal mineralization. Calcif Tissue Int. https:\/\/doi.org\/10.1007\/s00223-012-9672-8","journal-title":"Calcif Tissue Int"},{"key":"6536_CR33","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/ard.48.7.571","volume":"48","author":"AJ Chuck","year":"1989","unstructured":"Chuck AJ, Pattrick MG, Hamilton E et al (1989) Crystal deposition in hypophosphatasia: a reappraisal. Ann Rheum Dis 48:571\u2013576. https:\/\/doi.org\/10.1136\/ard.48.7.571","journal-title":"Ann Rheum Dis"},{"key":"6536_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.02.011","author":"MP Whyte","year":"2017","unstructured":"Whyte MP (2017) Hypophosphatasia: an overview For 2017. Bone. https:\/\/doi.org\/10.1016\/j.bone.2017.02.011","journal-title":"Bone"},{"key":"6536_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsb.2020.107603","author":"DJ Buss","year":"2020","unstructured":"Buss DJ, Reznikov N, McKee MD (2020) Crossfibrillar mineral tessellation in normal and Hyp mouse bone as revealed by 3D FIB-SEM microscopy. J Struct Biol. https:\/\/doi.org\/10.1016\/j.jsb.2020.107603","journal-title":"J Struct Biol"},{"key":"6536_CR36","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s00198-018-4571-0","volume":"29","author":"L L\u00f3pez-Delgado","year":"2018","unstructured":"L\u00f3pez-Delgado L, Riancho-Zarrabeitia L, Garc\u00eda-Unzueta MT et al (2018) Abnormal bone turnover in individuals with low serum alkaline phosphatase. Osteoporos Int 29:2147\u20132150. https:\/\/doi.org\/10.1007\/s00198-018-4571-0","journal-title":"Osteoporos Int"},{"key":"6536_CR37","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2014.1926","author":"IR Orriss","year":"2014","unstructured":"Orriss IR, Hajjawi MOR, Huesa C et al (2014) Optimisation of the differing conditions required for bone formation in vitro by primary osteoblasts from mice and rats. Int J Mol Med. https:\/\/doi.org\/10.3892\/ijmm.2014.1926","journal-title":"Int J Mol Med"},{"key":"6536_CR38","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s00198-011-1528-y","volume":"22","author":"F Barvencik","year":"2011","unstructured":"Barvencik F, TimoBeil F, Gebauer M et al (2011) Skeletal mineralization defects in adult hypophosphatasia\u2014a clinical and histological analysis. Osteoporos Int 22:2667\u20132675. https:\/\/doi.org\/10.1007\/s00198-011-1528-y","journal-title":"Osteoporos Int"},{"key":"6536_CR39","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s00223-020-00771-7","volume":"108","author":"NM Jandl","year":"2021","unstructured":"Jandl NM, Schmidt T, Rolvien T et al (2021) Genotype\u2013phenotype associations in 72 adults with suspected ALPL-associated hypophosphatasia. Calcif Tissue Int 108:288\u2013301. https:\/\/doi.org\/10.1007\/s00223-020-00771-7","journal-title":"Calcif Tissue Int"},{"key":"6536_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22031140","volume":"22","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Nam HK, Crouch S, Hatch NE (2021) Tissue nonspecific alkaline phosphatase function in bone and muscle progenitor cells: control of mitochondrial respiration and ATP production. Int J Mol Sci 22:1\u201320. https:\/\/doi.org\/10.3390\/ijms22031140","journal-title":"Int J Mol Sci"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06536-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-022-06536-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06536-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T09:08:10Z","timestamp":1668157690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-022-06536-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6536"],"URL":"https:\/\/doi.org\/10.1007\/s00198-022-06536-2","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]},"assertion":[{"value":"6 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AFL, MD and NRJ have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. NH has received research funding from Alexion, AstraZeneca Rare Disease and lecturer fees from Gedeon Richter and UCB. JEBJ is a board member in Eli Lilly, Amgen, Gedeon Richter and UCB, received funding from Eli Lilly and Amgen and consulting fees from UCB, Giliad and Amgen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}